Drugs / Genz-644282
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00942799 | Jul 2009 → Jan 2013 | cancer | Genzyme, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Genz-644282 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00942799 ↗ |
| Modality | Small molecule | — CHEMBL191958 ↗ |
| Route | Intravenous | “administered as an intravenous (IV) infusion” NCT00942799 ↗ |